We are live on ! Find out more
WF

Welch & Forbes Portfolio holdings

AUM $8.23B
1-Year Est. Return 17.62%
This Fund
S&P 500
This Quarter Est. Return
+5.66%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$3.75B
AUM Growth
-$52.5M
Cap. Flow
-$224M
Cap. Flow %
-5.98%
Top 10 Hldgs %
23.33%
Holding
360
New
28
Increased
96
Reduced
143
Closed
22

Top Buys

Rank Stock Value
1
EACQ
Easterly Acquisition Corp
EACQ
+$9.98M
2
AGN
Allergan plc
AGN
+$4.37M
3
PX
Praxair Inc
PX
+$3.81M
4
META icon
Meta Platforms (Facebook)
META
+$2.93M
5
FTSL icon
First Trust Senior Loan Fund ETF
FTSL
+$2.65M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$43M
2
CB icon
Chubb
CB
+$38.8M
3
ABT icon
Abbott
ABT
+$33.4M
4
AFL icon
Aflac
AFL
+$29.1M
5
T icon
AT&T
T
+$18.4M

Sector Composition

Rank Sector Weight
1 Healthcare 17.17%
2 Technology 16.95%
3 Financials 11.91%
4 Industrials 10.71%
5 Consumer Discretionary 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INTC icon
26
Intel
INTC
$455B
$43M 1.15%
932,350
-6,212
-0.7% -$271K
EMLP icon
27
First Trust North American Energy Infrastructure Fund
EMLP
$4.11B
$42.5M 1.13%
1,728,928
+40,550
+2% +$998K
RTN
28
DELISTED
Raytheon Company
RTN
$41.2M 1.1%
219,518
+9,393
+4% +$1.75M
META icon
29
Meta Platforms (Facebook)
META
$1.42T
$40.4M 1.08%
228,866
+16,566
+8% +$2.93M
PX
30
DELISTED
Praxair Inc
PX
$40M 1.07%
258,877
+25,710
+11% +$3.81M
CVX icon
31
Chevron
CVX
$392B
$39.3M 1.05%
313,687
+7,062
+2% +$837K
IRM icon
32
Iron Mountain
IRM
$36.4B
$39.2M 1.05%
1,039,896
-50,236
-5% -$1.99M
SLB icon
33
SLB Ltd
SLB
$73.6B
$38.8M 1.04%
575,917
-59,532
-9% -$3.86M
ROP icon
34
Roper Technologies
ROP
$38.8B
$38.4M 1.02%
148,067
+1,963
+1% +$504K
PFE icon
35
Pfizer
PFE
$143B
$35.4M 0.94%
1,028,952
-18,214
-2% -$621K
AMP icon
36
Ameriprise Financial
AMP
$48.3B
$32.5M 0.87%
191,606
+2,680
+1% +$429K
ADP icon
37
Automatic Data Processing
ADP
$106B
$32.1M 0.86%
274,314
-4,917
-2% -$562K
CMCSA icon
38
Comcast
CMCSA
$85B
$32.1M 0.86%
801,597
+49,371
+7% +$1.86M
GOOGL icon
39
Alphabet (Google) Class A
GOOGL
$4.36T
$30M 0.8%
569,400
-20,460
-3% -$1.06M
IDXX icon
40
Idexx Laboratories
IDXX
$44.1B
$29.6M 0.79%
189,012
-3,984
-2% -$627K
STT icon
41
State Street
STT
$50.6B
$29.1M 0.78%
298,004
+183
+0.1% +$17.5K
CGNX icon
42
Cognex
CGNX
$10.9B
$28.9M 0.77%
471,943
-37,151
-7% -$2.37M
CELG
43
DELISTED
Celgene Corp
CELG
$28.7M 0.77%
274,876
+10,277
+4% +$1.16M
MRK icon
44
Merck
MRK
$322B
$28.5M 0.76%
531,181
-30,477
-5% -$1.69M
CVS icon
45
CVS Health
CVS
$133B
$27.1M 0.72%
373,992
-99,481
-21% -$7.23M
COF icon
46
Capital One
COF
$128B
$26.7M 0.71%
268,292
-11,497
-4% -$1.05M
VRTX icon
47
Vertex Pharmaceuticals
VRTX
$121B
$26.7M 0.71%
178,253
-2,421
-1% -$358K
BUD icon
48
AB InBev
BUD
$170B
$24.6M 0.66%
220,872
+1,110
+0.5% +$131K
SWK icon
49
Stanley Black & Decker
SWK
$14.3B
$24.4M 0.65%
144,049
+3,338
+2% +$546K
TJX icon
50
TJX Companies
TJX
$174B
$24.4M 0.65%
638,286
-9,416
-1% -$341K
1
2
3 4 5

Similar funds

OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Welch & Forbes's Q4 2017 Portfolio in Review

As of Q4 2017, Welch & Forbes held 360 positions worth $3.75B, down 1.4% from $3.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Welch & Forbes withdrew a net $224M in Q4 2017, closing 22 positions and reducing 143 holdings. Its most notable exit was AbbVie, an estimated $43M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 20% a quarter earlier, followed by Technology and Financials.

Against the trend, Welch & Forbes opened a new position in Easterly Acquisition Corp worth $10M.

  • Welch & Forbes's largest Q4 2017 buy was Easterly Acquisition Corp: 994,036 shares worth $10M.
  • Welch & Forbes added most to Praxair Inc in Q4 2017, an estimated $3.81M increase.
  • Welch & Forbes's biggest Q4 2017 reduction was GE Aerospace, cutting an estimated $8.07M.
  • Welch & Forbes fully exited AbbVie in Q4 2017, selling an estimated $43M.
  • Welch & Forbes's ten largest holdings make up 23% of its $3.75B portfolio in Q4 2017.
  • Welch & Forbes opened 28 new positions and closed 22 in Q4 2017.
  • Welch & Forbes's portfolio value fell 1.4% quarter-over-quarter to $3.75B.

Based on Welch & Forbes's 13F filing for Q4 2017, filed 26 Jan 2018.